Biomerica, Inc. (BMRA) vs Ensysce Biosciences, Inc. (ENSC)
A side-by-side comparison of Biomerica, Inc. and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BMRA
Biomerica, Inc.
$2.14HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ENSC
Ensysce Biosciences, Inc.
$0.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BMRA vs ENSC
growth of $100 · dividends reinvested · last 9yBMRA -94.1% (-26.9%/yr)ENSC -100.0% (-71.6%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
BMRA ENSC
BMRA vs ENSC: by the numbers
- •BMRA is the larger company ($7M vs $7M market cap).
- •Both run net losses; BMRA's is the smaller (-84.79% vs -1084.23% net margin).
Metrics side by side
Valuation
| Metric | BMRA | ENSC |
|---|---|---|
| P/S ratio | 1.49 | 5.67 |
| P/B ratio | 2.51 | N/A |
Profitability
| Metric | BMRA | ENSC |
|---|---|---|
| Gross margin | 8.09% | 0.00% |
| Operating margin | -119.54% | 0.00% |
| Net margin | -84.79% | -1084.23% |
| ROE | -143.54% | N/A |
| ROIC | -117.93% | N/A |
Growth (annualized)
| Metric | BMRA | ENSC |
|---|---|---|
| Revenue CAGR (5Y) | -9.17% | N/A |
| Total return CAGR (5Y) | -46.66% | -86.22% |
Frequently asked
- How have BMRA and ENSC total returns compared?
- Over the past 5 years, BMRA delivered -46.66% and ENSC delivered -86.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.